Company intelligence / Profile preview

Asahi Kasei Corporation

Tokyo, Tokyo, Japanasahi-kasei.com ↗
Ownership
Public · 3407
Employees
~49295
Development stage
Other
01

Overview

Maintains top market shares in hemodialysis, therapeutic apheresis, transfusion therapy, and virus removal for biotherapeutic products[4]

Therapeutic areas
NephrologyHematology
Modalities
Medical devicesPharmaceuticalsBioprocess products
Industry
Therapeutic Medical Devices
02

Partnerships

Previously had a joint petrochemical venture with Dow Chemical[3]

Beyond the preview

Go deeper on Asahi Kasei Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asahi Kasei Corporation.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call